GG 623 GG 623 (Terazosin 5 mg)
Pill imprint GG 623 GG 623 has been identified as Terazosin hydrochloride 5 mg.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 5 mg
- 16.00 mm
- Prescription only
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|63739-0426||McKesson Packaging Services|
|54569-4875||A-S Medication Solutions, LLC (repackager)|
|54868-4248||Physicians Total Care Inc (repackager)|
|67544-0084||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
More about terazosin
- Other brands: Hytrin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.